Therapeutic Areas
Pet parents and pets enjoy a special relationship, particularly when the pets enjoy long and active lives. Unfortunately, serious diseases can threaten the health and longevity of pets, which can disrupt that relationship. TriviumVet is an innovative animal health company working on therapeutic solutions to solve unmet needs in the treatment of pet diseases, to help enhance the lives they share with the people who love them.
Gastroenterology
The world’s first veterinary registered PPI for canine gastric ulceration.
Age Related Decline
Tackling some of the most debilitating and chronic diseases of aging in companion animals.
Our Products
TriviumVet is addressing serious conditions in pets for whom there is no direct treatment and/or for which current treatments do not deliver satisfactory results. Read on to learn about the breakthrough solutions we are developing to help raise the standard of care for dogs and cats in several key areas.
TRIV202 - Under Development
Chronic, inflammatory diseases can decrease the length and quality of life of dogs and cats, which can be understandably upsetting to the people who love them. TRIV202 is an mTOR inhibition platform that is under development to treat chronic conditions in cats and dogs.
-
Hypertrophic Cardiomyopathy in Cats - A feline heart condition that can be caused by a thickening of the heart muscles.
-
Chronic Kidney Disease in Cats - A progressive condition that is characterized by a loss in kidney function and can lead to serious health problems for affected cats.
-
Cardiomyopathy in Dogs - A disease associated with enlargement of the heart and reduced heart function which can lead to congestive heart failure and lessened length and quality of life.
-
Age-related decline in Dogs and Cats - Some dogs and cats experience rapidly progressing loss of physical and cognitive function.
TRIV201 - Under Development
Neuropathic pain can result from diseases or injuries that affect a dog’s spinal cord or nerves. TRIV201 is a novel, beef-flavored painkiller for this serious condition.
Neuropathic Pain
A type of pain that comes from the animal’s nervous system, it can be severe and may be brought on by even a light touch.
TRIV 209 - Under Development
Dogs, like people, can develop gastric ulcers. TRIV209 is a veterinary proton pump inhibitor under development for the treatment of Gastric Ulceration in Dogs.
A Burning Issue
Gastric ulcerations can be debilitating to dogs, and stressful for owners. There’s a significant need for safe and effective treatments that relieve pets and owners from their damaging effects.
Take Part In Our Clinical Trials
TriviumVet is dedicated to raising the standard of treatment for some of the most serious medical conditions in pets. This requires quality clinical research, and for that we need your help. There are several different ways you can be part of our research driving therapeutic advances to enhance the lives of pets and the people who love them.
Having a pet with a serious health problem is frightening. Participating in a trial that is investigating a promising new therapy can not only provide hope for your pet, but it may also allow you and your pet to be part of research that brings hope to many more pets and owners.
The TriviumVet
WHY?
Every day we are awakened by a rousing purr, an energetic bark, or a slobbery kiss is a great day as far as we’re concerned. We do what we do for mornings like this, to help the pets we love live better quality, longer lives.
What gets us up in the morning?
OUR WHY is to bridge the treatment gaps in veterinary healthcare for our pets
OUR MISSION is to deliver innovative healthcare solutions for cats and dogs
OUR VISION as a company is to have a valuable impact on global pet healthcare
News
We at TriviumVet are thrilled to announce that the long-awaited HALT HCM Study is now live and recruiting cats in cardiac care centers across the United States! The study was officially launched at this year’s American College of Veterinary Internal Medicine (ACVIM) in Minneapolis.
